Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by harposon Jun 10, 2020 4:53am

313 Views

Post# 31131951

The door is wide open

This tweet from a top urooncologist Dr. Tom Powles is awesome for Theralase. Merck reported results from their phase 3 bladder cancer with Pembro

Pembrolizumab with or without chemotherapy not improving outcomes in front line metastatic bladder cancer. This is disappointing. Other front line trials such as Danube also struggling. Its underlines the difficulty of beating front line chemo.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal